First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer.
Zeng L, Song L, Liu L, Wu F, Xu Q, Yan H, Lin S, Jiang W, Wang Z, Deng L, Qin H, Zhang X, Xiao J, Liu M, Liu Z, Zhang L, Zhou C, Xiong Y, Wang Y, Zhang Y, Yang N.
Zeng L, et al. Among authors: xiao j.
Med. 2024 May 10;5(5):445-458.e3. doi: 10.1016/j.medj.2024.02.011. Epub 2024 Mar 22.
Med. 2024.
PMID: 38521070
Clinical Trial.